@ya_ronen הצוות שלי מפתח סדרה של כלים בדיוק בשביל זה. זה לא טריוויאלי בכלל וצריך להשקיע הרבה בהארנס ובחיבור ישיר לקוד של הדיזיין סיסטם. התוצאות שלנו לא רעות. אם יעניין אותך לשמוע, דיאם פתוח.
@Curiosity3033 לא רופא, אבל ממליץ לעשות דיפ ריסרץ׳ על הדברים האלה ולנסות לראות מה פרופיל הסיכון ולבקש ציטוט ממחקרים קליניים אם יש בנמצא. יש אנשים עם מחלות רקע שפטריות מסוימות לא עושות טוב. ליונס מיין יחסית בטוחה. ריישי אם אני זוכר נכון היו מקרים ששימוש יתר עשה בעיות. לבדוק!
Both are a middle-man, taking a cut. Seats in figma; Excessive token consumption in claude design.
The only way fw is building your own harness to get closest to your product truth, with the highest efficiency. Having an in house model helps too.
The biggest thing that’s missing for me in current llm experiences is having the model *watch* how i change their output and learn from it for next time without needing to repaste it and prompt it to change a skill for it.
Anyone solved it well (w tool or process?)
“You check the component. The component uses a variable. The variable is aliased to another variable. That variable references a mode. The mode is overridden at the instance level. The instance lives inside a nested component with a library swap applied.”
I'm looking to invest in cancer research and breakthrough treatment companies
Cancer is humanity's worst enemy, and unfortunately, it's one of the few frontier problems i don't see getting solved in the next 2-3 years.
I'll be able to write checks up to a few million (usually up to a million).
I will work extremely hard to help the founders. I'll leverage my network as much as possible to overcome bureaucracies and help hunt down talent for every company I'm investing in.
Things I'm particularly interested in:
1. Accelerating clinical trials: As AI gets smarter and allows novel hypotheses on new drug targets, clinical trials and bureaucracy will remain the biggest bottleneck to fight cacner.
2. Repurposed drugs: the current cost of Phase 3 clinical trials only allows patentable solutions to be economically viable. It resonates that are probably many other treatments and potentially impactful drugs that won't be included in the Standard of Care as they haven't gone through phase 3 clinical trials.
3. Personalized medicine: organoids, digital twin, faster cycle from biopsy -> identifying targets -> creating customised solutions, such as mRNA vaccines, custom Antibody-Drug Conjugates (ADCs), and novel ways of triggering one's immune system.
4. Improving measurement: Currently, the standard PET-CT method does not allow weekly measurement of disease progression. Identifying a superior method to allow weekly measurement of progression could be instrumental in cutting down the time it takes to find a drug the body respond to.
Anyone who can connect me to relevant companies will be widely appreciated
If you're 13 right now here's what you should do:
Spend all your time reading philosophy, sci fi, poetry, and history. Go to museums and look at every damn thing in there. Watch all the classic films and maybe every single movie made in the 90s. Learn how to write prose, document your thoughts and observations as thoroughly as you can. Go outside, play sports, learn how to play an instrument. Paint. Listen to all kinds of music.
Live life as humanly as you possibly can, and bring that love and energy back to whatever it is you decide to do in the future.
If you're 13 right now here's what you should do:
Spend all your time reading philosophy, sci fi, poetry, and history. Go to museums and look at every damn thing in there. Watch all the classic films and maybe every single movie made in the 90s. Learn how to write prose, document your thoughts and observations as thoroughly as you can. Go outside, play sports, learn how to play an instrument. Paint. Listen to all kinds of music.
Live life as humanly as you possibly can, and bring that love and energy back to whatever it is you decide to do in the future.
@emollick I see the last post as more reassuring—even if/when AGI exists, there is the physical world, the atoms, that AGI will have a harder time to capture.